{
  "meta": {
    "title": "Reproductive",
    "url": "https://brainandscalpel.vercel.app/reproductive-5c7908a9.html",
    "scrapedAt": "2025-11-30T11:13:18.817Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Testicular feminisation syndrome</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Klinefelter's syndrome</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Kallmann syndrome</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Noonan's syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 44-year-old man attends a fertility clinic. On examination, he is tall and slim, with bilateral gynaecomastia. Investigations show high levels of plasma gonadotropins. What is the likely diagnosis?</span></p>",
      "unique_key": "DT1196011",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196011,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Klinefelter's syndrome is the most likely diagnosis in a tall, infertile male with gynaecomastia and elevated gonadotropin levels.</p>\r\n<ul>\r\n<li>Klinefelter's syndrome (47, XXY) is the most common chromosomal cause of primary male hypogonadism.</li>\r\n<li>Characteristic findings: small, firm testes, azoospermia, tall stature with long legs, learning difficulties, and gynecomastia.</li>\r\n<li>Hypergonadotropic hypogonadism: &uarr;LH, &uarr;FSH with low testosterone levels.</li>\r\n<li>Infertility is a key feature, and testosterone therapy helps develop secondary sexual characteristics.</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>Primary hypogonadism &rarr; &uarr; FSH and LH due to lack of negative feedback.</li>\r\n<li>Gynaecomastia is common due to an altered testosterone-estrogen ratio.</li>\r\n<li>Patients often remain undiagnosed until they present with infertility.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Testicular feminisation syndrome (Option A):</strong> Genotypically male (46, XY) but phenotypically female with normal breast development and absent pubic/axillary hair.</p>\r\n<p><strong>Kallmann syndrome (Option C):</strong> Hypogonadotropic hypogonadism with <em>low</em> gonadotropins and anosmia contradicts high FSH/LH in this case.</p>\r\n<p><strong>Noonan's syndrome (Option D):</strong> Features short stature and cardiac defects (e.g., pulmonary stenosis), not associated with tall stature or gynaecomastia.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>Klinefelter's syndrome presents with tall stature, primary hypogonadism (&uarr;FSH, &uarr;LH), gynecomastia, and infertility in males.</p>",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Testicular feminisation syndrome</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Kallman's syndrome</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Marfan's syndrome</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Klinefelter's syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 19-year-old man is referred to the endocrine clinic by his general practitioner because he has poorly developed secondary sexual characteristics. He also reports anosmia. On examination, he has a lack of axillary and pubic hair, and small testicular volume. Investigations reveal:<br>Testosterone: 3.5 nmol/L (normal: 10-30)<br>Prolactin: 350 mU/L (normal: <450)<br>FSH: 2.2 IU/L (normal: 1-7)<br>LH: 1.8 IU/L (normal: 1-10)<br> What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1196017",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196017,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Kallmann syndrome is a form of hypogonadotropic hypogonadism associated with anosmia due to embryonic failure of migration of GnRH and olfactory neurons.</p>\r\n<ul>\r\n<li>Testosterone is low, but FSH and LH are inappropriately normal or low &rarr; central hypogonadism</li>\r\n<li>Anosmia is a hallmark clinical clue distinguishing Kallmann syndrome from other causes</li>\r\n<li>Gonadal development is impaired &rarr; delayed puberty, sparse secondary sexual hair, small testes</li>\r\n<li>Most commonly due to KAL1/ANOS1 mutation (X-linked recessive)</li>\r\n<li>Other features: cleft palate, hearing loss, renal agenesis in some patients</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>Kallmann syndrome is diagnosed by a combination of clinical features and biochemical hypogonadotropic hypogonadism</li>\r\n<li>MRI may reveal absent olfactory bulbs</li>\r\n<li>Treatment involves pulsatile GnRH or gonadotropin therapy to induce fertility</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Testicular feminisation syndrome (Option A):</strong> Complete androgen insensitivity; patient has female external phenotype despite 46, XY karyotype, not consistent with this male patient.</p>\r\n<p><strong>Marfan's syndrome (Option C):</strong> A connective tissue disorder; tall stature and lens dislocation but no hypogonadism or anosmia.</p>\r\n<p><strong>Klinefelter's syndrome (Option D):</strong> Causes primary hypogonadism (&uarr;LH/FSH), unlike the <em>low</em> gonadotropins seen here.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>Kallmann syndrome presents with delayed puberty, hypogonadotropic hypogonadism, and anosmia due to defective GnRH neuron migration.</p>",
      "correct_choice_id": 12,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Small testes</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Microphallus</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypospadias</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Anosmia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 12-year-old boy with bilateral gynaecomastia is being investigated. Which one of the features points towards hypogonadotropic hypogonadism being a likely cause?</span></p>",
      "unique_key": "DT1196025",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196025,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Anosmia is a key clinical clue to <strong>Kallmann syndrome</strong>, a genetic cause of <strong>hypogonadotropic hypogonadism</strong>.</p>\r\n<ul>\r\n<li>Hypogonadotropic hypogonadism is characterised by low FSH/LH, leading to reduced testosterone and impaired puberty.</li>\r\n<li>Kallmann syndrome results from the defective migration of GnRH-secreting and olfactory neurons, <strong>leading to delayed puberty and anosmia.</strong></li>\r\n<li>Other causes include pituitary or hypothalamic lesions, chronic illness, excessive exercise, and hyperprolactinemia.</li>\r\n<li>Microphallus and cryptorchidism suggest prenatal androgen deficiency but are not specific for hypogonadotropic aetiology.</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>Anosmia strongly supports a central (hypothalamic) origin.</li>\r\n<li>The most common genetic cause is a mutation in <strong>KAL1/ANOS1</strong>, usually X-linked.</li>\r\n<li>Onset is usually in adolescence with delayed puberty and absent secondary sexual characteristics.</li>\r\n</ul>\r\n<p>Genetic:</p>\r\n<p>Mutations in the following genes:</p>\r\n<ul>\r\n<li>KAL1</li>\r\n<li>FGFR1</li>\r\n<li>GNRHR</li>\r\n<li>PC1</li>\r\n</ul>\r\n<p>Acquired<u>:</u>(more common)</p>\r\n<ul>\r\n<li>Stress</li>\r\n<li>Athletes</li>\r\n<li>Chronic illness</li>\r\n<li>Obesity</li>\r\n<li>Hyperprolactinemia</li>\r\n<li>Sellar lesions</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Small testes (Option A):</strong> Seen in both hypo- and hypergonadotropic hypogonadism; not specific for central cause.</p>\r\n<p><strong>Microphallus (Option B):</strong> Suggests fetal androgen deficiency but not unique to central (hypogonadotropic) origin.</p>\r\n<p><strong>Hypospadias (Option C):</strong> Indicates abnormal androgen action or exposure in utero-usually a structural defect, not linked to central hypogonadism.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>Anosmia is the hallmark feature that points toward Kallmann syndrome, a form of hypogonadotropic hypogonadism.</p>",
      "correct_choice_id": 24,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Congenital adrenal hyperplasia</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperprolactinaemia</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Turner's syndrome</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Testicular feminisation syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 19-year-old young woman is referred to the endocrinologist with primary amenorrhoea. She is of normal height and weight. She has moderate hirsutism. A male cousin was seen in the clinic at the age of 8 years with precocious puberty. What is the most likely cause of her primary amenorrhoea?</span></p>",
      "unique_key": "DT1196029",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196029,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The combination of <strong>hirsutism</strong>, <strong>normal stature</strong>, <strong>primary amenorrhoea</strong>, and a <strong>family history of precocious puberty</strong> in a male cousin strongly suggests <strong>non-classic congenital adrenal hyperplasia (CAH)</strong>.</p>\r\n<ul>\r\n<li>CAH due to 21-hydroxylase deficiency causes excess androgen production from the adrenal cortex.</li>\r\n<li>In mild or non-classic CAH, girls present with hirsutism, amenorrhoea, virilisation, and normal external genitalia.</li>\r\n<li>Boys may present with early-onset puberty, which can explain the cousin's history.</li>\r\n<li>Diagnosis is confirmed by elevated 17-hydroxyprogesterone.</li>\r\n<li>Treatment: low-dose glucocorticoids to suppress ACTH and androgen overproduction.</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>Severe forms may present at birth with salt-wasting and ambiguous genitalia.</li>\r\n<li>Non-classic forms are milder and may present during adolescence with menstrual irregularities or infertility.</li>\r\n<li>The ACTH stimulation test is diagnostic if basal levels are equivocal.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Hyperprolactinaemia (Option B):</strong> Causes <em>secondary</em> amenorrhoea with galactorrhoea; does not explain hirsutism or family history.</p>\r\n<p><strong>Turner's syndrome (Option C):</strong> Causes primary amenorrhoea but with <em>short stature</em>, webbed neck, and streak ovaries, not hirsutism.</p>\r\n<p><strong>Testicular feminisation syndrome (Option D):</strong> XY genotype, phenotypic female with <em>no hirsutism</em> and <em>absent pubic/axillary hair</em>.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p><strong>Non-classic CAH</strong> should be suspected in females with <strong>primary amenorrhoea</strong>, <strong>hirsutism</strong>, and a <strong>family history of androgen excess</strong>.</p>",
      "correct_choice_id": 31,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Constitutional delay in growth and puberty</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Turner's syndrome</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Androgen insensitivity syndrome</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Congenital adrenal hyperplasia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">You are referred to a 15-year-old girl who has never previously attended medical care. Her mother is concerned that she has short stature and has still to commenced her periods. On examination, she is clearly below the 3rd centile for height. She appears to have excess skin around her neck and has poor development of secondary sexual characteristics. There is a click audible in the aortic area on auscultation. What diagnosis fits best with this clinical picture?</span></p>",
      "unique_key": "DT1196064",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196064,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>This presentation is classic for <strong>Turner syndrome</strong>, a genetic disorder characterised by a <strong>45, X karyotype</strong> and <strong>primary ovarian failure</strong>.</p>\r\n<ul>\r\n<li>Features include short stature, webbed neck, primary amenorrhoea, shield chest, and poor breast development.</li>\r\n<li>Cardiovascular anomalies such as a bicuspid aortic valve or coarctation are common (explains the aortic click).</li>\r\n<li>Gonadal dysgenesis results in streak ovaries, leading to a lack of estrogen and pubertal delay.</li>\r\n<li>Other findings: cubitus valgus, lymphedema, low posterior hairline, and renal anomalies (e.g., horseshoe kidney).</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>Most cases are diagnosed in adolescence due to <strong>primary amenorrhoea</strong>.</li>\r\n<li>Karyotyping confirms the diagnosis (typically 45, X).</li>\r\n<li>Estrogen replacement is required for the development of secondary sexual characteristics.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Constitutional delay (Option A):</strong> The most common cause of delayed puberty, but patients have normal growth patterns and no physical stigmata.</p>\r\n<p><strong>Androgen insensitivity syndrome (Option C):</strong> 46, XY karyotype, tall phenotype, breast development present, but no uterus or pubic/axillary hair.</p>\r\n<p><strong>Congenital adrenal hyperplasia (Option D):</strong> Causes <strong>virilisation</strong>, ambiguous genitalia, and signs of <strong>androgen excess</strong>, not short stature or amenorrhoea without virilisation.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p><strong>Turner syndrome</strong> should be suspected in girls with <strong>short stature</strong>, <strong>primary amenorrhoea</strong>, and physical stigmata such as <strong>webbed neck</strong> or <strong>cardiac anomalies</strong>.</p>",
      "correct_choice_id": 42,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Functional hypothalamic amenorrhea</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">PCOS</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Premature ovarian insufficiency</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Ovarian tumours</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The most common cause of anovulation in females is:</span></p>",
      "unique_key": "DT1196074",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196074,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Polycystic Ovary Syndrome (PCOS)</strong> is the <strong>most common cause</strong> of anovulation in reproductive-age women.</p>\r\n<ul>\r\n<li>It is a <strong>hyperandrogenic state</strong> with disrupted ovulatory cycles, menstrual irregularity, and subfertility.</li>\r\n<li>LH levels are typically elevated with a high LH: FSH ratio; insulin resistance is frequently present.</li>\r\n<li>Diagnosis is based on the <strong>Rotterdam criteria</strong>: at least 2 of 3 features oligo/anovulation, hyperandrogenism (clinical or biochemical), and polycystic ovaries on ultrasound.</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>Other causes of anovulation include:\r\n<ul>\r\n<li>Functional hypothalamic amenorrhea (e.g., stress, excessive exercise, eating disorders)</li>\r\n<li>Hyperprolactinemia</li>\r\n<li>Premature ovarian insufficiency (POI)</li>\r\n<li>Chronic systemic illness or thyroid dysfunction</li>\r\n</ul>\r\n</li>\r\n<li>Evaluation includes hormonal assays and imaging to determine aetiology.</li>\r\n<li>Management is tailored to fertility desires and metabolic control.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Functional hypothalamic amenorrhea (Option A):</strong> Common in athletes or stress-induced states, but not the leading cause overall.</p>\r\n<p><strong>Premature ovarian insufficiency (Option C):</strong> Causes anovulation but is less prevalent than PCOS.</p>\r\n<p><strong>Ovarian tumours (Option D):</strong> A Rare cause of anovulation, often present with mass effect or hormonal excess syndromes.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p><strong>PCOS</strong> is the leading cause of anovulation and menstrual irregularity in reproductive-aged women.</p>",
      "correct_choice_id": 52,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Testosterone replacement</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Desferrioxamine</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Venesection</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Insulin therapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 54-year-old diabetic man presents with malaise and loss of libido. On examination, there is evidence of hepatomegaly. Blood tests show Hb 14.1 g/dl (13-18), fasting glucose 144 mg/dl, serum iron 45 mmol/l (14-29) and serum ferritin 250,000 mmol/l (15-200). What would be the most appropriate treatment for his symptoms?</span></p>",
      "unique_key": "DT1196083",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196083,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The clinical picture suggests hereditary hemochromatosis with secondary hypogonadotropic hypogonadism due to iron deposition in the anterior pituitary and/or gonads.</p>\r\n<ul>\r\n<li>Elevated serum iron and markedly high ferritin levels are diagnostic clues.</li>\r\n<li>Hepatomegaly, diabetes, and hypogonadism (libido loss) are common systemic manifestations.</li>\r\n<li>Although venesection is the definitive treatment to reduce total body iron, it does not reverse existing hypogonadism.</li>\r\n<li>Testosterone replacement is required to restore libido and manage androgen deficiency symptoms.</li>\r\n<li>Desferrioxamine is used only in patients who cannot tolerate venesection (e.g., anaemia, severe cardiac failure).</li>\r\n<li>Insulin may be needed for glycemic control, but it will not address the loss of libido.</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>Hereditary hemochromatosis commonly presents in men &gt;40 years with liver dysfunction, diabetes, skin hyperpigmentation, and sexual dysfunction.</li>\r\n<li>Early diagnosis and iron reduction can prevent irreversible organ damage, but endocrine deficits often persist.</li>\r\n<li>Hormonal replacement is indicated if hypogonadism is symptomatic or biochemically confirmed.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p>Desferrioxamine (Option B): Chelation therapy is used rarely when venesection is contraindicated, not first-line.</p>\r\n<p>Venesection (Option C): Mainstay for reducing iron load, but doesn't resolve established hypogonadism.</p>\r\n<p>Insulin therapy (Option D): Controls diabetes but doesn't restore libido or treat hormonal deficiency.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>In hereditary hemochromatosis with established hypogonadism, testosterone replacement is essential to improve libido and sexual function.</p>",
      "correct_choice_id": 61,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase in testicular volume</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Growth of external genitalia</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Growth of pubic hair</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Change in voice</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 13-year-old boy is brought to your clinic with a complaint of delayed pubertal changes. While examining the patient, which of the following features is the first change to indicate that pubertal change may have commenced?</span></p>",
      "unique_key": "DT1196091",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196091,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The <strong>earliest clinical sign of puberty in boys</strong> is an <strong>increase in testicular volume</strong> to &gt;4 mL, measured with a Prader orchidometer.</p>\r\n<ul>\r\n<li>Testicular enlargement occurs before other secondary sexual characteristics.</li>\r\n<li>It is due to activation of the hypothalamic-pituitary-gonadal axis, increasing LH and FSH secretion.</li>\r\n<li>This is followed by:\r\n<ul>\r\n<li>Growth of the penis and scrotum</li>\r\n<li>Development of pubic and axillary hair</li>\r\n<li>Voice deepening</li>\r\n<li>Growth spurt</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p>In contrast, the first sign of puberty in girls is thelarche (breast budding), followed by pubarche and menarche.</p>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>Puberty onset in boys typically occurs between the ages of 9-14 years.</li>\r\n<li>Delayed puberty is defined as <strong>no testicular enlargement by age 14</strong>.</li>\r\n<li>Evaluation includes measurement of testicular size and Tanner staging.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Growth of external genitalia (Option B):</strong> Occurs <strong>after</strong> testicular enlargement.</p>\r\n<p><strong>Growth of pubic hair (Option C):</strong> A later event; part of adrenarche, not specific to gonadal activation.</p>\r\n<p><strong>Change in voice (Option D):</strong> Occurs late in puberty, usually in Tanner stage 4-5.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p><strong>Testicular enlargement &gt;4 mL</strong> is the <strong>first clinical sign</strong> of puberty onset in boys.</p>",
      "correct_choice_id": 71,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Luteinizing hormone</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Follicle-stimulating hormone</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Progesterone</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Estrogen</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 48-year-old woman presents with heavy menstrual bleeding. Which of the following hormones is most commonly associated with shedding of the endometrium during menstruation?</span></p>",
      "unique_key": "DT1196096",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196096,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Shedding of the endometrium during menstruation</strong> occurs due to the <strong>withdrawal of progesterone</strong> after involution of the corpus luteum.</p>\r\n<ul>\r\n<li>Progesterone, secreted by the corpus luteum in the luteal phase, stabilises the endometrial lining.</li>\r\n<li>Around day 24 of a 28-day cycle, the corpus luteum regresses (if no fertilisation occurs), leading to a sharp decline in progesterone and estradiol.</li>\r\n<li>This hormonal withdrawal causes ischemia, necrosis, and shedding of the functional layer of endometrium-manifesting as menstruation.</li>\r\n<li>LH and FSH play regulatory roles in folliculogenesis, but are not directly responsible for endometrial breakdown.</li>\r\n<li>Estrogen is the dominant hormone in the proliferative phase, promoting endometrial growth, not its shedding.</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>Menstrual cycle has two phases:\r\n<ul>\r\n<li>Follicular (proliferative): estrogen-driven</li>\r\n<li>Luteal (secretory): progesterone-dominated</li>\r\n</ul>\r\n</li>\r\n<li>Menstrual bleeding marks the start of a new cycle (day 1).</li>\r\n<li>Dysfunctional uterine bleeding in perimenopausal women is often anovulatory, with unopposed estrogen.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Luteinizing hormone (Option A):</strong> Triggers ovulation but is not involved in menstrual shedding.</p>\r\n<p><strong>Follicle-stimulating hormone (Option B):</strong> Stimulates follicular growth no direct role in menstruation.</p>\r\n<p><strong>Estrogen (Option D):</strong> Causes endometrial proliferation in early cycle withdrawal of progesterone is key to shedding.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p><strong>Progesterone withdrawal</strong> following corpus luteum regression is the primary trigger for <strong>endometrial shedding during menstruation</strong>.</p>",
      "correct_choice_id": 83,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Estrogen</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Gonadotropin-releasing hormone</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Recombinant FSH</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Adequate diet and observation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 15-year-old girl presents with primary amenorrhoea. She represents her school in athletics and is now training for the national championships. Which of the following would be the most appropriate treatment for her?</span></p>",
      "unique_key": "DT1196107",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196107,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>This patient most likely has functional hypothalamic amenorrhoea, a reversible form of central hypogonadism triggered by:</strong></p>\r\n<ul>\r\n<li>Strenuous physical activity</li>\r\n<li>Caloric restriction</li>\r\n<li>Psychological stress</li>\r\n</ul>\r\n<p>These factors suppress the hypothalamic GnRH pulse generator, leading to decreased FSH and LH secretion and delayed puberty or amenorrhoea.</p>\r\n<ul>\r\n<li>Since the underlying issue is functional and reversible, lifestyle correction with adequate nutrition and stress management is the first-line treatment.</li>\r\n<li>Hormonal therapies (e.g., estrogen, GnRH, FSH) are not required initially, as normal menstrual cycles typically resume<strong> with restoration of energy balance.</strong></li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>Functional hypothalamic amenorrhoea is common in athletes, ballet dancers, and those with eating disorders.</li>\r\n<li>Menarche may be delayed or cycles may cease after initial onset.</li>\r\n<li>A thorough history and nutritional assessment are key.</li>\r\n<li>If uncorrected, it can lead to bone loss due to hypoestrogenism.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Estrogen (Option A): </strong>Reserved for long-standing hypoestrogenism causing bone loss, not first-line here.</p>\r\n<p><strong>GnRH (Option B): </strong>Used in diagnostic or fertility settings, not needed for functional suppression.</p>\r\n<p><strong>Recombinant FSH (Option C): </strong>Used in assisted reproduction, not in primary amenorrhoea from lifestyle causes.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>Functional hypothalamic amenorrhoea due to intense training is best managed with nutritional support and reduced physical stress.</p>",
      "correct_choice_id": 94,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Lack of testosterone formation</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased 5 alpha reductase</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased aromatase activity</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Dysfunctional androgen receptor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 16-year-old girl presents with primary amenorrhoea. General physical examination reveals no abnormality.  Breast development appears to be normal with scant pubic hair growth. On karyotyping, she is found to have XY genotype. What is the most probable cause of her condition?</span></p>",
      "unique_key": "DT1196114",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196114,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>This clinical picture is classic for Complete Androgen Insensitivity Syndrome (CAIS), also known as testicular feminisation syndrome.</strong></p>\r\n<ul>\r\n<li><strong>These individuals </strong>are genotypically male (46, XY) but phenotypically female.</li>\r\n<li>The underlying cause is a mutation in the androgen receptor, rendering tissues insensitive to testosterone and dihydrotestosterone (DHT).</li>\r\n<li>Despite adequate testosterone production by intra-abdominal testes, target tissues cannot respond due to defective receptors.</li>\r\n<li>M&uuml;llerian inhibiting substance (MIS/AMH) is still produced &rarr; no uterus or upper vagina.</li>\r\n<li>Testosterone is aromatised to estrogen, resulting in normal breast development.</li>\r\n<li>Pubic and axillary hair is scanty due to androgen insensitivity.</li>\r\n<li>Primary amenorrhoea is often <strong>the presenting complaint in adolescence.</strong></li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>Gonads are intra-abdominal testes, often requiring removal post-puberty to avoid malignancy.</li>\r\n<li>Diagnosis is confirmed via karyotyping and androgen receptor mutation analysis.</li>\r\n<li>Vaginal length is typically shortened; uterus is absent.</li>\r\n<li>Psychological support and gender-affirming counselling are essential.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Lack of testosterone formation (Option A): </strong>Would lead to poor breast development and ambiguous genitalia not seen here.</p>\r\n<p><strong>Decreased 5 alpha reductase (Option B): </strong>Affects DHT production, not testosterone; genital ambiguity is present, not full female phenotype.</p>\r\n<p><strong>Increased aromatase activity (Option C): </strong>Would increase estrogen, but doesn't explain XY genotype with absent androgen action.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>Androgen insensitivity syndrome is caused by mutated androgen receptors, leading to a female phenotype in an XY individual with primary amenorrhoea.</p>",
      "correct_choice_id": 104,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Growth hormone</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Progesterone</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Estrogen</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulsatile GnRH</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 12-year-old girl presents with short stature, webbed neck and primary amenorrhoea. Given the likely clinical diagnosis, which hormone would be most appropriate to treat this condition?</span></p>",
      "unique_key": "DT1196125",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196125,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The clinical features are suggestive of Turner syndrome (45, X), a chromosomal disorder characterised by gonadal dysgenesis and primary ovarian failure.</p>\r\n<ul>\r\n<li>Estrogen is essential for the development of secondary sexual characteristics, including breast development, endometrial proliferation, and epiphyseal fusion.</li>\r\n<li>In Turner syndrome, the ovaries are non-functional (streak gonads), and endogenous estrogen production is absent.</li>\r\n<li>Exogenous estrogen therapy is started around age 11-13 to mimic normal pubertal development.</li>\r\n<li>After full estrogen priming, cyclical progesterone may be added to induce withdrawal bleeding and protect the endometrium.</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>Growth hormone therapy is initiated earlier (usually before age 11) to improve final height.</li>\r\n<li>Estrogen therapy is lifelong and also protects against osteoporosis and cardiovascular disease.</li>\r\n<li>Patients should undergo karyotype testing, cardiac imaging (for aortic anomalies), and renal ultrasound.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Growth hormone (Option A)</strong>: Helps increase final height, but does not address hypoestrogenism or amenorrhoea.</p>\r\n<p><strong>Progesterone (Option B)</strong>: Used after estrogen priming to induce cyclical bleeding, not the initial therapy.</p>\r\n<p><strong>Pulsatile GnRH (Option D)</strong>: Ineffective due to non-functional ovaries, no response to gonadotropins.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>In Turner syndrome, estrogen therapy is essential to initiate and maintain pubertal development and protect long-term health.</p>",
      "correct_choice_id": 113,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Dopamine</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">TSH</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">GnRH</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">TRH</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">You review a 28-year-old girl who has been referred with amenorrhoea. She is noted on routine screening to have a raised prolactin level. The patient is keen to know about prolactin physiology. Which of the following is the primary physiological regulator of prolactin production?</span></p>",
      "unique_key": "DT1196132",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196132,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Dopamine</strong> from the hypothalamus is the <strong>major inhibitory regulator</strong> of prolactin secretion by the anterior pituitary.</p>\r\n<ul>\r\n<li>Unlike other anterior pituitary hormones, prolactin is tonically inhibited under normal conditions.</li>\r\n<li>Dopaminergic neurons in the hypothalamus suppress prolactin secretion via D2 receptors on lactotrophs.</li>\r\n<li>Prolactin levels increase physiologically during pregnancy, lactation, sleep, and stress.</li>\r\n<li>Pathological hyperprolactinemia may result from:\r\n<ul>\r\n<li>Dopamine antagonists (e.g., metoclopramide, antipsychotics)</li>\r\n<li>Prolactinomas</li>\r\n<li>Hypothyroidism (via increased TRH)</li>\r\n<li>Chest wall injury or stimulation</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>Symptoms of hyperprolactinemia in women:\r\n<ul>\r\n<li>Amenorrhoea</li>\r\n<li>Galactorrhoea</li>\r\n<li>Infertility</li>\r\n</ul>\r\n</li>\r\n<li>In men:\r\n<ul>\r\n<li>Reduced libido</li>\r\n<li>Erectile dysfunction</li>\r\n</ul>\r\n</li>\r\n<li>Dopamine agonists (e.g., cabergoline, bromocriptine) are used for treatment.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>TSH (Option B):</strong> Regulates thyroid hormone, not prolactin.</p>\r\n<p><strong>GnRH (Option C):</strong> Regulates LH/FSH not involved in prolactin regulation.</p>\r\n<p><strong>TRH (Option D):</strong> Can mildly stimulate prolactin but is <strong>not the primary regulator</strong>.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p><strong>Dopamine is the primary physiological inhibitor</strong> of prolactin secretion by the anterior pituitary.</p>",
      "correct_choice_id": 121,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreases tubal motility</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibits ovulation</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Creates an unfavorable endometrium for implantation</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Thickens cervical mucus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 22-year-old woman with a history of migraine is prescribed a progestin-only pill. What is the main contraceptive mechanism of action of this drug?</span></p>",
      "unique_key": "DT1196148",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196148,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Progestin-only pills (POPs), also known as mini-pills, exert their primary contraceptive effect by thickening the cervical mucus, making it impermeable to sperm.</strong></p>\r\n<ul>\r\n<li><strong>This effect</strong> is dose-dependent and occurs even when ovulation is not consistently inhibited.</li>\r\n<li>POPs are often prescribed when estrogen-containing pills are contraindicated, such as in women with migraine, thromboembolic risk, or lactation.</li>\r\n<li>Although progestins may also:\r\n<ul>\r\n<li>Alter tubal motility</li>\r\n<li>Disrupt endometrial receptivity</li>\r\n<li>Suppress ovulation<br />- These effects are secondary or inconsistent in standard low-dose progestin-only pills.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li><strong>POPs must be taken at </strong>the same time daily for op<strong>timal efficacy.</strong></li>\r\n<li><strong>Breakthrough bleeding is a common side effect.</strong></li>\r\n<li><strong>Depot progestins (e.g., DMPA) and LNG-IUS suppress ovulation more consistently due to higher systemic levels.</strong></li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Decreases tubal motility (Option A): </strong>May occur, but not the primary contraceptive mechanism and can increase ectopic risk.</p>\r\n<p><strong>Inhibits ovulation (Option B): </strong>Inconsistent with low-dose POPs; not the main mechanism.</p>\r\n<p><strong>Creates unfavourable endometrium (Option C):</strong> May occur but is a secondary effect not sufficient alone for contraception.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>The primary mechanism of progestin-only pills is thickening of cervical mucus, which prevents sperm penetration.</p>",
      "correct_choice_id": 134,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Follicle size of 20 mm on ultrasound scan</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase in basal body temperature</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Positive Spinnbarkeit test</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Raised LH level</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following investigations is most likely to indicate that ovulation is imminent?</span></p>",
      "unique_key": "DT1196154",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196154,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The <strong>LH surge</strong> is the most <strong>reliable predictor</strong> that <strong>ovulation is imminent</strong>, typically occurring <strong>24-36 hours</strong> after the LH peak.</p>\r\n<ul>\r\n<li>The LH surge stimulates the final maturation and rupture of the dominant follicle.</li>\r\n<li>LH levels can be detected in serum or urine, and are widely used in ovulation prediction kits.</li>\r\n<li>This makes raised LH the most precise and timely marker for imminent ovulation, especially in fertility monitoring.</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>Ovulation typically occurs around <strong>day 14 of a 28-day cycle</strong>, but the <strong>LH surge</strong> is the best biochemical indicator.</li>\r\n<li><strong>Basal body temperature</strong> rises <strong>after</strong> ovulation due to progesterone.</li>\r\n<li><strong>Ultrasound</strong> helps monitor follicular growth but does not confirm ovulation timing.</li>\r\n<li><strong>Spinnbarkeit test</strong> reflects estrogen activity and fertile cervical mucus but lacks timing accuracy.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Follicle size of 20 mm (Option A):</strong> Suggests maturity but not timing-ovulation typically occurs at 22-24 mm.</p>\r\n<p><strong>Increase in basal body temperature (Option B):</strong> Occurs <strong>after ovulation</strong> due to progesterone effect.</p>\r\n<p><strong>Positive Spinnbarkeit test (Option C):</strong> Indicates estrogenic environment but <strong>does not predict exact ovulation timing</strong>.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p><strong>Raised LH level</strong> is the most accurate and timely indicator that <strong>ovulation is about to occur</strong>.</p>",
      "correct_choice_id": 144,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Bacterial vaginosis</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Chlamydial endocervicitis</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Vaginal warts</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Genital herpes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 37-year-old woman presents to her GP with a vaginal discharge. She has been taking the combined oral contraceptive pill (OCP). What is the most common infection associated with the use of the OCP?</span></p>",
      "unique_key": "DT1196164",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196164,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Use of <strong>combined oral contraceptive pills (OCPs)</strong> has been associated with an <strong>increased risk of Chlamydia trachomatis infection</strong>, particularly <strong>endocervicitis</strong>.</p>\r\n<ul>\r\n<li>Estrogen and progestin alter cervical mucus, making it more permissive to ascending pathogens like Chlamydia.</li>\r\n<li>OCPs may also cause ectropion of the endocervix, exposing columnar epithelium, which is more susceptible to Chlamydia.</li>\r\n<li>Chlamydial infections are often asymptomatic or present with mucopurulent cervical discharge, intermenstrual bleeding, or pelvic discomfort.</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>Other STIs (e.g., HPV, HSV) may coexist but are not directly increased due to OCP use.</li>\r\n<li>Regular screening and barrier protection should be advised, especially for women on OCPs without consistent condom use.</li>\r\n<li>Bacterial vaginosis is more linked to altered vaginal flora and douching, not directly to OCP use.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Bacterial vaginosis (Option A):</strong> Common cause of discharge, but not directly associated with OCP use.</p>\r\n<p><strong>Vaginal warts (Option C):</strong> Caused by HPV; no established increased incidence with OCP use.</p>\r\n<p><strong>Genital herpes (Option D):</strong> Caused by HSV; OCPs do not significantly affect risk of herpes acquisition.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p><strong>Chlamydial endocervicitis</strong> is the most common infection linked to <strong>OCP use</strong>, due to altered cervical epithelium and mucus.</p>",
      "correct_choice_id": 152,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Gonadotropin deficiency</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Weight-related amenorrhoea</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Polycystic ovarian disease</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Primary ovarian failure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 23-year-old woman presents for review. She is concerned on this occasion because she has not had a period for 5 months. She is 1.76 m in height and weighs only 43.7 kg. A pregnancy test is negative, and thyroid function testing is normal. Which diagnosis fits best with this woman's clinical picture?</span></p>",
      "unique_key": "DT1196172",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196172,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>The most likely cause of secondary amenorrhoea in this underweight woman is weight-related (functional hypothalamic) amenorrhoea.</strong></p>\r\n<ul>\r\n<li><strong>Menstruation re</strong>quires a minimum body fat percentage (~17-22%) for normal GnRH pulsatility.</li>\r\n<li>In this case, her BMI is markedly low (~14.1 kg/m&sup2;), which suppresses the hypothalamic-pituitary-ovarian (HPO) axis.</li>\r\n<li>This results in low GnRH, leading to decreased FSH/LH, and amenorrhoea biochemically mimicking gonadotropin deficiency.</li>\r\n<li>Seen in conditions like anorexia nervosa, excessive physical training, or severe caloric restriction.</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li><strong>The hormonal profile in weight-related amenorrhoea may resemble hypogonadotropic hypogonadism.</strong></li>\r\n<li><strong>Restoration of normal weight and energy intake is usually sufficient to resume menses.</strong></li>\r\n<li><strong>Estrogen deficiency from chronic hypoestrogenism can lead to bone loss.</strong></li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Gonadotropin deficiency (Option A): </strong>May have similar labs but is usually central (organic) or congenital, not due to weight loss.</p>\r\n<p><strong>Polycystic ovarian disease (Option C): </strong>Often associated with obesity, hirsutism, and hyperandrogenism, not underweight status.</p>\r\n<p><strong>Primary ovarian failure (Option D): </strong>Characterised by elevated FSH/LH, occurs in women &lt;40, but typically with normal or low-normal weight.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>Weight-related amenorrhoea from undernutrition or low BMI suppresses the HPO axis and is a common reversible cause of secondary amenorrhoea in young women.</p>",
      "correct_choice_id": 162,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">12</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">10</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">20</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">25</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">According to the International Consensus PCOS guidelines, the number of follicles per ovary (2-9 mm) required to make an ultrasonographic diagnosis of PCO pattern is:</span></p>",
      "unique_key": "DT1196181",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196181,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>The 2023 International Evidence-Based Guidelines for PCOS, developed by a global consortium, updated t</strong>he ultrasonographic criteria for polycystic ovarian morphology:</p>\r\n<ul>\r\n<li>On modern transvaginal ultrasound, a follicle number per ovary (FNPO) of &ge;20 follicles (each 2-9 mm in diameter) is required for the diagnosis of PCO morphology.</li>\r\n<li>This is a revised cut-off from the older Rotterdam criteria, which used &ge;12 follicles per ovary (based on older, lower-resolution machines).</li>\r\n<li>Additionally, an ovarian volume &gt;10 cm&sup3; can<strong> also be considered supportive of the diagnosis.</strong></li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>The diagnosis of PCOS still requires two out of three Rotterdam criteria:\r\n<ol>\r\n<li>Oligo- or anovulation</li>\r\n<li>Clinical or biochemical hyperandrogenism</li>\r\n<li>Polycystic ovaries on ultrasound</li>\r\n</ol>\r\n</li>\r\n<li>Diagnosis should not be made by ultrasound alone in adolescents (&lt;8 years post-menarche), as multifollicular ovaries are physiologically normal.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>12 (Option A): Based on 2003 Rotterdam criteria using older ultrasound technology.</strong></p>\r\n<p><strong>10 (Option B): Below all accepted thresholds; not diagnostic.</strong></p>\r\n<p><strong>25 (Option D): This cut-off was recommended by the Androgen Excess Society but is higher than the consensus threshold.</strong></p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>As per the International PCOS guidelines, &ge;20 follicles (2-9 mm) per ovary on ultrasound is required to define polycystic ovarian morphology.</p>",
      "correct_choice_id": 173,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Warfarin therapy</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Digoxin therapy</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Furosemide</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Ranitidine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\"> A 64-year-old man presents with evidence of gynaecomastia. He has been taking long-term digitalis and warfarin therapy for persistent atrial fibrillation. In addition, he takes another tablet for heartburn. Results of tests for androgens, HCG, liver function and thyroid function are all normal. What is the most likely cause of his gynaecomastia?</span></p>",
      "unique_key": "DT1196193",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196193,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Digoxin is a well-documented cause of gynecomastia, even at therapeutic levels.</p>\r\n<ul>\r\n<li>The mechanism involves digoxin's estrogen-like effects, as it can bind to estrogen receptors.</li>\r\n<li>Among drugs, a helpful mnemonic for common offenders is \"DISCO\":\r\n<ul>\r\n<li>Digoxin</li>\r\n<li>Isoniazid</li>\r\n<li>Spironolactone</li>\r\n<li>Cimetidine</li>\r\n<li>Cyproterone</li>\r\n<li>Oestrogen</li>\r\n</ul>\r\n</li>\r\n<li>In this patient, hormonal workup is normal, making drug-induced gynecomastia the most plausible cause.</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>Gynecomastia in elderly men is often multifactorial, considering both medications and physiological hormonal imbalance.</li>\r\n<li>In addition to drugs, consider thyrotoxicosis, liver disease, and HCG/estrogen-producing <strong>tumours</strong>.</li>\r\n</ul>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>Among common medications, digoxin is a recognised cause of drug-induced gynecomastia due to its estrogenic activity.</p>",
      "correct_choice_id": 182,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Polycystic ovarian syndrome (PCOS)</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperprolactinaemia</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Androgen-secreting tumour</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Cushing's disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 23-year-old student presents for review. She is distressed by the fact that she is overweight and is embarrassed by excessive facial hair. She also notices that she appears to have more generalised body hair than other women. On further history, she can sometimes miss a couple of menses, but pregnancy testing is consistently negative. Her mother apparently had similar problems in her youth, took a while to conceive and now has type-2 diabetes. Testosterone is just above the upper limit of normal range, her LH: FSH ratio is increased, and prolactin is normal. Which diagnosis fits best with this woman's clinical picture?</span></p>",
      "unique_key": "DT1196211",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196211,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The clinical picture-hirsutism, oligomenorrhoea, obesity, and a family history of diabetes-along with biochemical evidence of hyperandrogenism and increased LH: FSH ratio, is characteristic of PCOS.</p>\r\n<ul>\r\n<li>PCOS affects ~3-10% of reproductive-aged women.</li>\r\n<li>Common features include:\r\n<ul>\r\n<li>Hyperandrogenism (acne, hirsutism, male-pattern hair)</li>\r\n<li>Chronic anovulation/oligomenorrhoea</li>\r\n<li>Polycystic ovarian morphology on ultrasound</li>\r\n</ul>\r\n</li>\r\n<li>Insulin resistance is common, increasing risk of type 2 diabetes.</li>\r\n<li>LH: FSH ratio &gt;2:1 is commonly seen.</li>\r\n<li>Mild elevation of testosterone is expected, unlike the marked elevation seen in virilizing tumours.</li>\r\n<li>Related Important Points:</li>\r\n<li>Diagnostic criteria (Rotterdam): any 2 of 3 - oligo/anovulation, hyperandrogenism, and PCO morphology</li>\r\n<li>Treatment includes:\r\n<ul>\r\n<li>Weight loss and lifestyle modification</li>\r\n<li>OCPs to regulate menses and lower androgens</li>\r\n<li>Letrozole/Clomiphene citrate for ovulation induction</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202404239ea412e5-12f2-4260-82ae-e65790b35e9a.jpg\">\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p>Hyperprolactinaemia (Option B): Unlikely since prolactin is normal.</p>\r\n<p>Androgen-secreting tumour (Option C): Would cause marked testosterone elevation and rapid <strong>virilisation</strong>, not mild chronic signs.</p>\r\n<p>Cushing's disease (Option D): May mimic PCOS, but typically includes striae, moon face, proximal weakness, and glucose intolerance not seen here.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>PCOS should be suspected in young women with hirsutism, irregular menses, mild androgen excess, and family history of metabolic disease.</p>",
      "correct_choice_id": 191,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Diabetes mellitus is less likely to cause these conditions</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Penile pain is a common association</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Autonomic neuropathy is unlikely to be present</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">&beta;-blockers and thiazide diuretics may exacerbate the problem</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 64-year-old man presents to the diabetes clinic for review. He complains of difficulty in maintaining penile erection despite having a normal libido. Which of the following is true regarding his condition?</span></p>",
      "unique_key": "DT1196218",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196218,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Erectile dysfunction (ED) is a common complication of long-standing diabetes, primarily due to autonomic neuropathy and vascular dysfunction.</p>\r\n<ul>\r\n<li>Up to 30-50% of diabetic men develop ED within 6 years of diagnosis.</li>\r\n<li>ED often occurs despite normal libido, making it particularly distressing.</li>\r\n<li>Autonomic neuropathy affects parasympathetic innervation necessary for erection.</li>\r\n<li>&beta;-blockers and thiazide diuretics impair vascular and neural mechanisms, further worsening erectile issues.</li>\r\n<li>PDE-5 inhibitors (e.g., sildenafil) are first-line treatments but often require higher doses in diabetic patients.</li>\r\n<li>Alternative therapies include alprostadil injections or vacuum erection devices.</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p>Diabetes mellitus is less likely to cause these conditions (Option A): Diabetes is a major cause of erectile dysfunction, especially with autonomic involvement.</p>\r\n<p>Penile pain is a common association (Option B): Diabetic erectile dysfunction is not typically associated with pain.</p>\r\n<p>Autonomic neuropathy is unlikely to be present (Option C): Autonomic dysfunction is a key contributor to diabetic ED and may also cause gastroparesis or postural hypotension.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>In diabetic men with erectile dysfunction, medications such as &beta;-blockers and thiazide diuretics may worsen symptoms and should be reviewed during evaluation.</p>",
      "correct_choice_id": 204,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">The LH/FSH ratio is likely to be normal</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Sex hormone-binding globulin is low in 50% of sufferers with this condition</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Testosterone levels are usually normal</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Fertility is usually unaffected by this condition</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 26-year-old overweight woman presents with hirsutism and oligomenorrhoea. She has been unable to conceive for 18 months. The adrenals appear normal on ultrasound scanning, but an ovarian ultrasound scan reveals numerous small follicles in both ovaries. Which of the following is likely to fit best with her diagnosis?</span></p>",
      "unique_key": "DT1196222",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196222,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>The clinical features and ultrasound findings are characteristic of Polycystic Ovary Syndrome (PCOS).</strong></p>\r\n<ul>\r\n<li><strong>PCOS is a</strong>ssociated with insulin resistance, which reduces hepatic synthesis of sex hormone-binding globulin (SHBG), resulting in lower SHBG levels in nearly 50% of patients.</li>\r\n<li>Lower SHBG increases free androgen levels, contributing to hirsutism and acne.</li>\r\n<li>The LH/FSH ratio is often elevated, commonly &gt;2:1.</li>\r\n<li>Total testosterone and DHEAS levels are often mildly raised.</li>\r\n<li>Infertility is common due to anovulation, affecting about 30-40% o<strong>f patients.</strong></li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li><strong>Rotterdam criteria for PCOS diagnosis (need 2 of 3):</strong>\r\n<ul>\r\n<li><strong>Oligo/anovulation</strong></li>\r\n<li><strong>Hyperandrogenism (clinical or biochemical)</strong></li>\r\n<li><strong>Polycystic ovaries on ultrasound</strong></li>\r\n</ul>\r\n</li>\r\n<li><strong>Associated metabolic abnormalities:</strong>\r\n<ul>\r\n<li>Impaired glucose tolerance (up to 40%)</li>\r\n<li>Type 2 diabetes mellitus (10%)</li>\r\n<li>Dyslipidemia</li>\r\n</ul>\r\n</li>\r\n<li>Treatment includes:\r\n<ul>\r\n<li>Weight reduction and lifestyle changes</li>\r\n<li>Metformin for insulin resistance and fertility restoration</li>\r\n<li>Clomiphene citrate or letrozole for ovulation induc<strong>tion<br /> </strong></li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>The LH/FSH ratio is likely to be normal (Option A): LH/FSH ratio is typically elevated, not normal.</strong></p>\r\n<p><strong>Testosterone levels are usually normal (Option C): Testosterone is mildly elevated in many patients.</strong></p>\r\n<p><strong>Fertility is usually unaffected by this condition (Option D): Infertility is a common feature due to chronic anovulation.</strong></p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p><strong>PCOS often presents with hirsutism, menstrual irregularities, and infertility; SHBG is reduced in about half the cases due to hyperinsulinemia.</strong></p>",
      "correct_choice_id": 212,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Premature ovarian failure</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Polycystic ovarian syndrome (PCOS)</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Androgen-secreting adrenal tumour</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypogonadotropic hypogonadism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 23-year-old woman presents with 13 months of amenorrhoea. For the past few months, she has been experiencing hot flushes, night sweats, mood changes and pain on intercourse. FSH has been > 40 mIU/l on two separate occasions, and her serum estradiol level is low. TSH is normal. Fasting blood glucose is normal. The pregnancy test is negative. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1196226",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196226,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>This patient&rsquo;s high FSH (&gt;40 mIU/L on 2 occasions), low estradiol, and &gt;12 months of amenorrhoea in a woman under 40 years is classic for Premature Ovarian Failure (POF), also termed Primary Ovarian Insufficiency (POI).</strong></p>\r\n<ul>\r\n<li><strong>Occur</strong>s in ~1% of women under 40 years</li>\r\n<li>Represents hypergonadotropic hypogonadism (&uarr;FSH, &darr;estradiol)</li>\r\n<li>Common features: vasomotor symptoms, infertility, and vaginal dryness</li>\r\n<li>Autoimmune etiologies contribute to ~20% of cases</li>\r\n<li>Recovery of fertility is rare (~5%)</li>\r\n<li>Long-term consequences: osteoporosis, cardiovascular risk, and psychosocial burden</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li><strong>Diagnostic criteria include:</strong>\r\n<ul>\r\n<li><strong>Amenorrhoea for &ge;4 months</strong></li>\r\n<li><strong>FSH &gt;40 mIU/L, repeated at least 1 month apart</strong></li>\r\n</ul>\r\n</li>\r\n<li><strong>Causes: autoimmune, genetic (e.g. Fragile X premutation), iatrogenic, idiopathic</strong></li>\r\n<li><strong>Syndromic associations: Fragile X, Galactosemia, Blepharophimosis-ptosis syndrome</strong></li>\r\n<li><strong>Hormone replacement therapy is essential to reduce long-term complications</strong></li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>Polycystic ovarian syndrome (Option B): </strong>Estrogen is usually normal; FSH is low or normal, not elevated to menopausal levels.</p>\r\n<p><strong>Androgen-secreting adrenal tumour (Option C): </strong>Presents with rapid virilisation and very high testosterone or DHEAS estrogen and FSH usually remain normal.</p>\r\n<p><strong>Hypogonadotropic hypogonadism (Option D): </strong>Characterised by low FSH and low estradiol this patient has high FSH, making this diagnosis incompatible.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>Persistently elevated FSH with low estradiol in a young woman with amenorrhoea strongly indicates Premature Ovarian Failure (POI).</p>",
      "correct_choice_id": 221,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">LH</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">FSH</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">Testosterone</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">GnRH</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Kallmann's syndrome is due congenital synthesis defect of?</span></p>",
      "unique_key": "DT1196229",
      "question_audio": null,
      "question_video": null,
      "map_id": 1196229,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Kallmann's syndrome is a form of congenital hypogonadotropic hypogonadism </strong>characterised<strong> by deficient synthesis of GnRH and associated anosmia.</strong></p>\r\n<ul>\r\n<li><strong>Ca</strong>used by defective GnRH neuron migration from the olfactory placode to the hypothalamus during embryogenesis.</li>\r\n<li>Most commonly due to mutation in the KAL1 gene located on Xp22.3.</li>\r\n<li>Deficiency of GnRH leads to low LH and FSH, resulting in low testosterone and delayed/absent puberty.</li>\r\n<li>Anosmia results from underdevelopment of the olfactory bulbs, which share the same embryologic origin as GnRH neurons.</li>\r\n</ul>\r\n<p><strong>Related Important Points:</strong></p>\r\n<ul>\r\n<li>Inheritance: X-linked recessive (KAL1), but autosomal dominant and recessive variants exist</li>\r\n<li>Associated anomalies: Cleft lip/palate, renal agenesis, midline defects</li>\r\n<li>Treatment: Pulsatile GnRH therapy or hCG + FSH therapy to induce puberty and fertility</li>\r\n<li>It differs from constitutional delay of puberty by the absence of progression without<strong> treatment</strong></li>\r\n</ul>\r\n<p><strong>Explanation of other options:</strong></p>\r\n<p><strong>LH (Option A): </strong>LH is low due to lack of GnRH stimulation, not the primary defect.</p>\r\n<p><strong>FSH (Option B): </strong>FSH levels are also low secondary to deficient GnRH, not due to defective synthesis.</p>\r\n<p><strong>Testosterone (Option C): </strong>Testosterone is reduced downstream, secondary to low LH not due to a synthesis defect in testosterone itself.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<p>Kallmann's syndrome is due to congenital GnRH deficiency, leading to hypogonadotropic hypogonadism with anosmia.</p>",
      "correct_choice_id": 234,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}